(Total Views: 307)
Posted On: 05/31/2023 11:15:47 AM
Post# of 118

$TGTX News Article - TG Therapeutics Announces Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI (ublituximab-xiiy) in Multiple Sclerosis to be Presented at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting https://marketwirenews.com/news-releases/tg-t...83057.html


My Twitter: WhyteStocks